BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34794117)

  • 1. Reasons for Nonuse, Discontinuation of Use, and Acceptance of Additional Functionalities of a COVID-19 Contact Tracing App: Cross-sectional Survey Study.
    Walrave M; Waeterloos C; Ponnet K
    JMIR Public Health Surveill; 2022 Jan; 8(1):e22113. PubMed ID: 34794117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes Toward Mobile Apps for Pandemic Research Among Smartphone Users in Germany: National Survey.
    Buhr L; Schicktanz S; Nordmeyer E
    JMIR Mhealth Uhealth; 2022 Jan; 10(1):e31857. PubMed ID: 35072646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Dutch COVID-19 Notification App: Lessons Learned From a Mixed Methods Evaluation Among End Users and Contact-Tracing Employees.
    van Gend JE; van 't Klooster JWJR; Bolman CAW; van Gemert-Pijnen JEWC
    JMIR Form Res; 2022 Nov; 6(11):e38904. PubMed ID: 36074930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoption of a Contact Tracing App for Containing COVID-19: A Health Belief Model Approach.
    Walrave M; Waeterloos C; Ponnet K
    JMIR Public Health Surveill; 2020 Sep; 6(3):e20572. PubMed ID: 32755882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public Adoption of and Trust in the NHS COVID-19 Contact Tracing App in the United Kingdom: Quantitative Online Survey Study.
    Dowthwaite L; Fischer J; Perez Vallejos E; Portillo V; Nichele E; Goulden M; McAuley D
    J Med Internet Res; 2021 Sep; 23(9):e29085. PubMed ID: 34406960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Roles of General Health and COVID-19 Proximity in Contact Tracing App Usage: Cross-sectional Survey Study.
    Witteveen D; de Pedraza P
    JMIR Public Health Surveill; 2021 Aug; 7(8):e27892. PubMed ID: 34081602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Venn Diagrams to Evaluate Digital Contact Tracing: Panel Survey Analysis.
    Daniore P; Nittas V; Moser A; Höglinger M; von Wyl V
    JMIR Public Health Surveill; 2021 Dec; 7(12):e30004. PubMed ID: 34874890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best Practice Guidance for Digital Contact Tracing Apps: A Cross-disciplinary Review of the Literature.
    O'Connell J; Abbas M; Beecham S; Buckley J; Chochlov M; Fitzgerald B; Glynn L; Johnson K; Laffey J; McNicholas B; Nuseibeh B; O'Callaghan M; O'Keeffe I; Razzaq A; Rekanar K; Richardson I; Simpkin A; Storni C; Tsvyatkova D; Walsh J; Welsh T; O'Keeffe D
    JMIR Mhealth Uhealth; 2021 Jun; 9(6):e27753. PubMed ID: 34003764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Trust in COVID-19 Contact-Tracing Apps Using the Human-Computer Trust Scale: Online Survey Study.
    Sousa S; Kalju T
    JMIR Hum Factors; 2022 Jun; 9(2):e33951. PubMed ID: 35699973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drivers of Acceptance of COVID-19 Proximity Tracing Apps in Switzerland: Panel Survey Analysis.
    von Wyl V; Höglinger M; Sieber C; Kaufmann M; Moser A; Serra-Burriel M; Ballouz T; Menges D; Frei A; Puhan MA
    JMIR Public Health Surveill; 2021 Jan; 7(1):e25701. PubMed ID: 33326411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concerns and Misconceptions About the Australian Government's COVIDSafe App: Cross-Sectional Survey Study.
    Thomas R; Michaleff ZA; Greenwood H; Abukmail E; Glasziou P
    JMIR Public Health Surveill; 2020 Nov; 6(4):e23081. PubMed ID: 33048826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To Use or Not to Use a COVID-19 Contact Tracing App: Mixed Methods Survey in Wales.
    Jones K; Thompson R
    JMIR Mhealth Uhealth; 2021 Nov; 9(11):e29181. PubMed ID: 34698645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness, Policy, and User Acceptance of COVID-19 Contact-Tracing Apps in the Post-COVID-19 Pandemic Era: Experience and Comparative Study.
    Liu M; Zhou S; Jin Q; Nishimura S; Ogihara A
    JMIR Public Health Surveill; 2022 Oct; 8(10):e40233. PubMed ID: 36190741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to the Large-Scale Adoption of a COVID-19 Contact Tracing App in Germany: Survey Study.
    Blom AG; Wenz A; Cornesse C; Rettig T; Fikel M; Friedel S; Möhring K; Naumann E; Reifenscheid M; Krieger U
    J Med Internet Res; 2021 Mar; 23(3):e23362. PubMed ID: 33577466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Influencing the Adoption of Contact Tracing Applications: Systematic Review and Recommendations.
    Oyibo K; Sahu KS; Oetomo A; Morita PP
    Front Digit Health; 2022; 4():862466. PubMed ID: 35592459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technology, Privacy, and User Opinions of COVID-19 Mobile Apps for Contact Tracing: Systematic Search and Content Analysis.
    Elkhodr M; Mubin O; Iftikhar Z; Masood M; Alsinglawi B; Shahid S; Alnajjar F
    J Med Internet Res; 2021 Feb; 23(2):e23467. PubMed ID: 33493125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of App-Based Contact Tracing for COVID-19: Cross-Country Survey Study.
    Altmann S; Milsom L; Zillessen H; Blasone R; Gerdon F; Bach R; Kreuter F; Nosenzo D; Toussaert S; Abeler J
    JMIR Mhealth Uhealth; 2020 Aug; 8(8):e19857. PubMed ID: 32759102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ready or Not for Contact Tracing? Investigating the Adoption Intention of COVID-19 Contact-Tracing Technology Using an Extended Unified Theory of Acceptance and Use of Technology Model.
    Walrave M; Waeterloos C; Ponnet K
    Cyberpsychol Behav Soc Netw; 2021 Jun; 24(6):377-383. PubMed ID: 33017171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public attitudes towards COVID-19 contact tracing apps: A UK-based focus group study.
    Williams SN; Armitage CJ; Tampe T; Dienes K
    Health Expect; 2021 Apr; 24(2):377-385. PubMed ID: 33434404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated With Using the COVID-19 Mobile Contact-Tracing App Among Individuals Diagnosed With SARS-CoV-2 in Amsterdam, the Netherlands: Observational Study.
    Ritsema F; Bosdriesz JR; Leenstra T; Petrignani MWF; Coyer L; Schreijer AJM; van Duijnhoven YTHP; van de Wijgert JHHM; Schim van der Loeff MF; Matser A
    JMIR Mhealth Uhealth; 2022 Aug; 10(8):e31099. PubMed ID: 35867842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.